Skip to content

Clinical trials

Genital Neoplasms, Female trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genital Neoplasms, Female Country / region: China Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20161
20181
20202
20212
20221
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status5
Active, not recruiting2
Recruiting2
Completed1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Xiaoxiang Chen2
Huazhong University of Science and Technology1
Lei Li1
Liu Zi1
Mabwell (Shanghai) Bioscience Co., Ltd.1
Peking Union Medical College Hospital1
Sichuan Cancer Hospital and Research Institute1
Tongji Hospital1
Wenjun Cheng1
Zhejiang Cancer Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genital Neoplasms, Female11
Ovarian Neoplasms6
Neoplasms by Site4
Uterine Cervical Neoplasms4
Carcinoma3
Carcinoma, Ovarian Epithelial3
Endometrial Neoplasms3
Genital Diseases, Female3
Neoplasms3
Neoplasms by Histologic Type3

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.